Yukiko Nishiguchi Selected Research

Yukiko Nishiguchi Research Topics

Disease

21	Neoplasms (Cancer) 12/2021 - 09/2015
13	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2015
7	Stomach Neoplasms (Stomach Cancer) 04/2022 - 03/2019
6	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2017
6	Squamous Cell Carcinoma of Head and Neck 05/2020 - 08/2016
3	Adenocarcinoma 04/2023 - 03/2017
3	Colonic Neoplasms (Colon Cancer) 08/2020 - 07/2017
2	Pancreatic Ductal Carcinoma 07/2022 - 11/2019
2	Polyps 11/2021 - 05/2020
2	Adenoma (Adenomas) 07/2021 - 05/2020
2	Body Weight (Weight, Body) 03/2021 - 01/2021
2	Disease Progression 05/2020 - 11/2018
2	Breast Neoplasms (Breast Cancer) 05/2020 - 09/2015
1	Hypoxia (Hypoxemia) 04/2023
1	Inflammation (Inflammations) 01/2022
1	Glioma (Gliomas) 01/2022
1	Infections 11/2021
1	Metaplasia 11/2021
1	Aberrant Crypt Foci 07/2021
1	Carcinogenesis 07/2021
1	Lymphatic Metastasis 05/2021
1	Diabetes Mellitus 08/2020
1	Testicular Neoplasms (Testicular Cancer) 05/2020
1	Starvation 07/2017
1	Collagenous Colitis 03/2017
1	Fibrosis (Cirrhosis) 03/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2017

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 11/2021 - 05/2016
6	Claudin-4IBA 05/2020 - 12/2015
5	Fluorouracil (Carac)FDA LinkGeneric 05/2021 - 07/2017
3	Gemcitabine FDA Link 04/2023 - 03/2017
3	Linoleic Acid (Linoleate)IBA 01/2022 - 07/2017
3	Hemoglobins (Hemoglobin)IBA 03/2021 - 08/2020
3	Fatty Acids (Saturated Fatty Acids)IBA 08/2020 - 07/2017
3	Cisplatin (Platino)FDA LinkGeneric 12/2019 - 09/2015
2	lauric acid (dodecanoic acid)IBA 04/2023 - 07/2017
2	Glucose (Dextrose)FDA LinkGeneric 05/2021 - 07/2017
2	HMGB1 Protein (HMG1)IBA 05/2021 - 12/2019
2	Proton Pump InhibitorsIBA 05/2020 - 03/2017
2	Clostridium enterotoxinIBA 05/2020 - 01/2020
2	Tamoxifen FDA LinkGeneric 05/2020 - 09/2015
2	elaidic acidIBA 07/2017 - 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2023
1	pterostilbeneIBA 04/2022
1	Sunitinib (Sutent)FDA Link 04/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Calcibiotic Root Canal SealerIBA 01/2022
1	MicroRNAs (MicroRNA)IBA 12/2021
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 11/2021
1	8-Hydroxy-2'-DeoxyguanosineIBA 11/2021
1	AzoxymethaneIBA 07/2021
1	ThapsigarginIBA 05/2021
1	CytokinesIBA 05/2021
1	Glyoxal (Ethanedial)IBA 05/2021
1	BiglycanIBA 08/2020
1	SugarsIBA 08/2020
1	Insulin (Novolin)FDA Link 08/2020
1	Cholecystokinin B ReceptorIBA 05/2020
1	Aldehyde DehydrogenaseIBA 05/2020
1	GastrinsIBA 05/2020
1	Cyclin D1IBA 05/2020
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 05/2020
1	Cadherins (E-Cadherin)IBA 05/2020
1	AntigensIBA 05/2020
1	emerinIBA 05/2020
1	Diphosphonates (Bisphosphonates)IBA 05/2020
1	ClaudinsIBA 01/2020
1	ethyl pyruvateIBA 12/2019
1	tanshinoneIBA 12/2019
1	folfirinoxIBA 11/2019
1	Homeodomain Proteins (Proteins, Homeobox)IBA 03/2019
1	Tight Junction ProteinsIBA 12/2018
1	Growth Factor ReceptorsIBA 12/2018
1	Cetuximab (Erbitux)FDA Link 12/2018
1	Type 2 Angiotensin ReceptorIBA 11/2018
1	Messenger RNA (mRNA)IBA 11/2018
1	Angiotensin IIIBA 11/2018
1	Losartan (Cozaar)FDA LinkGeneric 11/2018
1	Angiotensin Receptor AntagonistsIBA 11/2018
1	MagnesiumIBA 05/2018
1	KetonesIBA 07/2017
1	Carnitine (L-Carnitine)FDA LinkGeneric 07/2017
1	3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA 07/2017
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 07/2017
1	Ketone BodiesIBA 07/2017
1	Lipid PeroxidesIBA 03/2017
1	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2017
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 03/2017
1	CollagenIBA 03/2017
1	Collagen Type III (Type III Collagen)IBA 03/2017
1	Protons (Proton)IBA 03/2017
1	Oleic Acid (Oleate)IBA 01/2017
1	Trans Fatty AcidsIBA 01/2017

Therapy/Procedure

4	Gastrectomy 07/2021 - 01/2021
2	Drug Therapy (Chemotherapy) 04/2023 - 12/2015
2	Splenectomy 07/2021 - 01/2021
2	Neoadjuvant Therapy 05/2021 - 12/2019
2	Therapeutics 07/2017 - 12/2015
1	Molecular Targeted Therapy 04/2022
1	Lymph Node Excision (Lymph Node Dissection) 01/2021